Skip to Content
Merck
All Photos(1)

Documents

521175

Sigma-Aldrich

4-Ethynylbiphenyl

97%

Sign Into View Organizational & Contract Pricing


About This Item

Linear Formula:
C6H5C6H4C≡CH
CAS Number:
Molecular Weight:
178.23
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22

Assay

97%

mp

88-91 °C (lit.)

SMILES string

C#Cc1ccc(cc1)-c2ccccc2

InChI

1S/C14H10/c1-2-12-8-10-14(11-9-12)13-6-4-3-5-7-13/h1,3-11H

InChI key

BPBNKCIVWFCMJY-UHFFFAOYSA-N

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

A Wade et al.
The Biochemical journal, 184(3), 509-517 (1979-12-15)
1. 4-Ethynylbiphenyl undergoes extensive metabolism in the rat and the rabbit, involving aromatic hydroxylation and oxidation of the ethynyl group. No metabolites containing the intact ethynyl group were detected. 2. In the rat unchanged 4-ethynylbiphenyl was concentrated initially in the
Branched polyphenylenes by repetitive Diels-Alder cycloaddition.
Shifrina ZB, et al.
Macromolecules, 33(10), 3525-3529 (2000)
Rajneesh Misra et al.
Dalton transactions (Cambridge, England : 2003), 43(12), 4854-4861 (2014-02-01)
A series of meso arylethynyl BODIPYs (2a-2h) were designed and synthesized by the Pd-catalyzed Sonogashira cross-coupling reaction. The effects of the donor on the photophysical properties of the BODIPYs were explored. The DFT optimized structures and crystal structures show the
Hitoshi Fukuda et al.
The Japanese journal of antibiotics, 55(3), 270-280 (2002-08-30)
Convulsant activity of pazufloxacin mesilate (PZFX mesilate), a new quinolone antibacterial agent for intravenous use, in combination with nonsteroidal anti-inflammatory drug (NSAID) was investigated in mice after intravenous or intracerebroventricular administration. Following results were obtained. 1. In combination with 4-biphenylacetic
Cu-Promoted Oxidative Trifluoromethylation of Terminal Alkynes with Difluoromethylene Phosphobetaine.
Deng X, et al.
Chin. J. Chem., 32(8), 689-693 (2014)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service